The role of physical activity in metabolic homeostasis before and after the onset of type 2 diabetes: an IMI DIRECT study.


Journal

Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777

Informations de publication

Date de publication:
04 2020
Historique:
received: 29 08 2019
accepted: 29 11 2019
pubmed: 1 2 2020
medline: 2 4 2021
entrez: 1 2 2020
Statut: ppublish

Résumé

It is well established that physical activity, abdominal ectopic fat and glycaemic regulation are related but the underlying structure of these relationships is unclear. The previously proposed twin-cycle hypothesis (TC) provides a mechanistic basis for impairment in glycaemic control through the interactions of substrate availability, substrate metabolism and abdominal ectopic fat accumulation. Here, we hypothesise that the effect of physical activity in glucose regulation is mediated by the twin-cycle. We aimed to examine this notion in the Innovative Medicines Initiative Diabetes Research on Patient Stratification (IMI DIRECT) Consortium cohorts comprised of participants with normal or impaired glucose regulation (cohort 1: N ≤ 920) or with recently diagnosed type 2 diabetes (cohort 2: N ≤ 435). We defined a structural equation model that describes the TC and fitted this within the IMI DIRECT dataset. A second model, twin-cycle plus physical activity (TC-PA), to assess the extent to which the effects of physical activity in glycaemic regulation are mediated by components in the twin-cycle, was also fitted. Beta cell function, insulin sensitivity and glycaemic control were modelled from frequently sampled 75 g OGTTs (fsOGTTs) and mixed-meal tolerance tests (MMTTs) in participants without and with diabetes, respectively. Abdominal fat distribution was assessed using MRI, and physical activity through wrist-worn triaxial accelerometry. Results are presented as standardised beta coefficients, SE and p values, respectively. The TC and TC-PA models showed better fit than null models (TC: χ These analyses partially support the mechanisms proposed in the twin-cycle model and highlight mechanistic pathways through which insulin sensitivity and liver fat mediate the association between physical activity and glycaemic control.

Identifiants

pubmed: 32002573
doi: 10.1007/s00125-019-05083-6
pii: 10.1007/s00125-019-05083-6
pmc: PMC7054368
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

744-756

Subventions

Organisme : Medical Research Council
ID : MC_UU_12015/3
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00006/4
Pays : United Kingdom
Organisme : European Commission
ID : CoG-2015_681742_NASCENT [P.W.F.]
Pays : International
Organisme : Medical Research Council
ID : MC_UU_12015/3 [S.Bra.]
Pays : United Kingdom
Organisme : Novo Nordisk
ID : STAR Novo Nordisk co-financed PhD fellowship [R.W.
Pays : International
Organisme : MedImmune
ID : PhD Fellowship [T.W.]
Pays : International
Organisme : Novo Nordisk Fonden
ID : NNF18OC0031650 (Postdoctoral Fellowship)[R.W.K.]
Pays : International
Organisme : Innovative Medicines Initiative
ID : 115317 (DIRECT)
Pays : International

Commentaires et corrections

Type : ErratumIn

Références

Psychol Bull. 1990 Mar;107(2):238-46
pubmed: 2320703
Diabetes. 2019 Aug;68(8):1681-1691
pubmed: 31088856
Lancet. 2018 Feb 10;391(10120):541-551
pubmed: 29221645
Med Sci Sports Exerc. 2015 Aug;47(8):1727-34
pubmed: 25386715
Diabetologia. 2016 Mar;59(3):462-71
pubmed: 26625858
Radiology. 2008 May;247(2):550-7
pubmed: 18349314
Diabetologia. 2008 Jan;51(1):130-8
pubmed: 18008059
Diabetes. 1988 Dec;37(12):1595-607
pubmed: 3056758
Lancet. 2016 Sep 24;388(10051):1325-36
pubmed: 27475270
Gastroenterology. 2008 Jul;135(1):122-30
pubmed: 18474251
Diabetes Care. 2013 Apr;36(4):1047-55
pubmed: 23520370
PLoS One. 2017 Apr 3;12(4):e0174660
pubmed: 28369092
Diabetologia. 2005 Apr;48(4):748-51
pubmed: 15744532
Genet Epidemiol. 2011 Nov;35(7):592-6
pubmed: 21769934
Diabetes Care. 2010 Dec;33(12):e147-67
pubmed: 21115758
Diabetologia. 2008 Oct;51(10):1781-9
pubmed: 18726585
Diabetologia. 2019 Sep;62(9):1601-1615
pubmed: 31203377
J Pers Soc Psychol. 1986 Dec;51(6):1173-82
pubmed: 3806354
Cell Metab. 2018 Oct 2;28(4):547-556.e3
pubmed: 30078554
PLoS One. 2015 May 07;10(5):e0126825
pubmed: 25950180
PLoS One. 2016 Dec 9;11(12):e0167472
pubmed: 27936024
PLoS One. 2017 Feb 10;12(2):e0171816
pubmed: 28187151
Lancet. 2016 Apr 2;387(10026):1377-1396
pubmed: 27115820
Diabetes Care. 2007 Nov;30(11):2916-21
pubmed: 17666465
Int J Obes (Lond). 2019 Nov;43(11):2333-2342
pubmed: 30940917
Diabetes Metab. 2013 May;39(3):217-25
pubmed: 23541222
Diabet Med. 2009 Dec;26(12):1185-92
pubmed: 20002468
Diabetologia. 2014 Jun;57(6):1132-42
pubmed: 24695864
Med Sci Sports Exerc. 2015 May;47(5):983-9
pubmed: 25207926
Diabetes. 2009 Apr;58(4):773-95
pubmed: 19336687
J Histochem Cytochem. 2005 Sep;53(9):1087-97
pubmed: 15923354
Diabetes Care. 2018 Jan;41(Suppl 1):S13-S27
pubmed: 29222373
Diabetologia. 2016 Aug;59(8):1753-9
pubmed: 27179658
Diabetes Obes Metab. 2008 Nov;10 Suppl 4:77-87
pubmed: 18834435
Prog Nucl Magn Reson Spectrosc. 2013 Aug;73:56-80
pubmed: 23962884
Hepatology. 2009 May;49(5):1537-44
pubmed: 19291789
Diabetes Care. 2001 Mar;24(3):539-48
pubmed: 11289482

Auteurs

Robert W Koivula (RW)

Department of Clinical Sciences, Lund University, Genetic and Molecular Epidemiology, CRC, Skåne University Hospital Malmö, Building 91, Level 12, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden. robert.koivula@med.lu.se.
Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. robert.koivula@med.lu.se.

Naeimeh Atabaki-Pasdar (N)

Department of Clinical Sciences, Lund University, Genetic and Molecular Epidemiology, CRC, Skåne University Hospital Malmö, Building 91, Level 12, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden.

Giuseppe N Giordano (GN)

Department of Clinical Sciences, Lund University, Genetic and Molecular Epidemiology, CRC, Skåne University Hospital Malmö, Building 91, Level 12, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden.

Tom White (T)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.

Jerzy Adamski (J)

Research Unit Molecular Endocrinology and Metabolism, Genome Analysis Center, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.
Lehrstuhl für Experimentelle Genetik, Technische Universität München, Freising-Weihenstephan, Germany.
Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Republic of Singapore.

Jimmy D Bell (JD)

Research Centre for Optimal Health, Department of Life Sciences, University of Westminister, London, UK.

Joline Beulens (J)

Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam University Medical Centre, location VU University Medical Center, Amsterdam, the Netherlands.

Søren Brage (S)

MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Cambridge, UK.
Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.

Søren Brunak (S)

The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark.

Federico De Masi (F)

The Novo Nordisk Foundation Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark.

Emmanouil T Dermitzakis (ET)

Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
Institute of Genetics and Genomics in Geneva (iGE3), University of Geneva, Geneva, Switzerland.
Swiss Institute of Bioinformatics, Geneva, Switzerland.

Ian M Forgie (IM)

Population Health & Genomics, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK.

Gary Frost (G)

Nutrition and Dietetics Research Group, Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, Hammersmith Campus, London, UK.

Torben Hansen (T)

Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark.
The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.

Tue H Hansen (TH)

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.

Andrew Hattersley (A)

NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, UK.
Institute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.

Tarja Kokkola (T)

Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.

Azra Kurbasic (A)

Department of Clinical Sciences, Lund University, Genetic and Molecular Epidemiology, CRC, Skåne University Hospital Malmö, Building 91, Level 12, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden.

Markku Laakso (M)

Department of Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.

Andrea Mari (A)

Institute of Neurosciences, National Research Council, Padova, Italy.

Timothy J McDonald (TJ)

NIHR Exeter Clinical Research Facility, University of Exeter Medical School, Exeter, UK.

Oluf Pedersen (O)

The Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, Denmark.

Femke Rutters (F)

Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, Amsterdam University Medical Centre, location VU University Medical Center, Amsterdam, the Netherlands.

Jochen M Schwenk (JM)

Affinity Proteomics, Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.

Harriet J A Teare (HJA)

HeLEX, Nuffield Department of Population Health, University of Oxford, Old Road Campus, Headington, Oxford, UK.

E Louise Thomas (EL)

Research Centre for Optimal Health, Department of Life Sciences, University of Westminister, London, UK.

Ana Vinuela (A)

Department of Genetic Medicine and Development, University of Geneva Medical School, Geneva, Switzerland.
Institute of Genetics and Genomics in Geneva (iGE3), University of Geneva, Geneva, Switzerland.
Swiss Institute of Bioinformatics, Geneva, Switzerland.

Anubha Mahajan (A)

Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.

Mark I McCarthy (MI)

Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
NIHR Oxford Biomedical Research Centre, Churchill Hospital, Oxford, UK.
Human Genetics, Genentech, South San Francisco, CA, USA.

Hartmut Ruetten (H)

Sanofi-Aventis Deutschland GmbH, R&D, Frankfurt am Main, Germany.

Mark Walker (M)

Institute of Cellular Medicine (Diabetes), Newcastle University, Newcastle upon Tyne, UK.

Ewan Pearson (E)

Population Health & Genomics, School of Medicine, University of Dundee, Ninewells Hospital, Dundee, UK.

Imre Pavo (I)

Eli Lilly Regional Operations GmbH, Vienna, Austria.

Paul W Franks (PW)

Department of Clinical Sciences, Lund University, Genetic and Molecular Epidemiology, CRC, Skåne University Hospital Malmö, Building 91, Level 12, Jan Waldenströms gata 35, SE-205 02, Malmö, Sweden.
Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
Department of Nutrition, Harvard School of Public Health, Boston, MA, USA.
Department of Public Health & Clinical Medicine, Section for Medicine, Umeå University Hospital, Umeå, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH